SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemours Co – ‘8-K’ for 2/11/21

On:  Thursday, 2/11/21, at 4:31pm ET   ·   For:  2/11/21   ·   Accession #:  1564590-21-5566   ·   File #:  1-36794

Previous ‘8-K’:  ‘8-K’ on 1/22/21 for 1/21/21   ·   Next:  ‘8-K’ on 3/2/21 for 3/1/21   ·   Latest:  ‘8-K’ on / for 5/3/21

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/11/21  Chemours Co                       8-K:2,5,8,9 2/11/21   12:2M                                     ActiveDisclosure/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     32K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    398K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     33K 
 8: R1          Document And Entity Information                     HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- cc-8k_20210211_htm                  XML     14K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.LAB  XBRL Labels -- cc-20210211_lab                       XML     56K 
 6: EX-101.PRE  XBRL Presentations -- cc-20210211_pre                XML     34K 
 4: EX-101.SCH  XBRL Schema -- cc-20210211                           XSD     19K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
12: ZIP         XBRL Zipped Folder -- 0001564590-21-005566-xbrl      Zip     71K 

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:   C:   C:   C:   C:   C: 
 i false  i 0001627223 0001627223 2021-02-11 2021-02-11







FORM  i 8-K






 i February 11, 2021

Date of Report (Date of Earliest Event Reported)

 i The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)


 i Delaware


 i 001-36794


 i 46-4845564

(State or Other Jurisdiction




(I.R.S. Employer

Of Incorporation)


File Number)


Identification No.)


 i 1007 Market Street

 i Wilmington,  i Delaware  i 19801

(Address of principal executive offices)


Registrant’s telephone number, including area code:  i (302)  i 773-1000


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class


Trading Symbol(s)


Name of Exchange on Which Registered

 i Common Stock ($0.01 par value)


 i CC


 i New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






Item 2.02Results of Operations and Financial Condition.


On February 11, 2021, The Chemours Company (the “Company”) issued a press release regarding its fourth quarter and full year 2020 financial results. A copy of the press release is furnished hereto as Exhibit 99.1.


The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.


Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On February 11, 2021, the Company issued a press release, announcing that E. Bryan Snell, who serves as the Company’s President, Titanium Technologies, will retire from the Company. The retirement will become effective after the completion of a transition period which has yet to be determined. Effective March 1, 2021, Edwin (Ed) Sparks will become President, Titanium Technologies. Mr. Sparks will also continue as President of the Chemical Solutions business, which he has led since 2018.


A copy of the press release is furnished hereto as Exhibit 99.2.


Item 8.01Other Events.


On February 11, 2021, the Company issued a press release, announcing leadership appointments resulting from its fourth quarter change in segment reporting structure. The change results in the bifurcation of the Company’s former Fluoroproducts segment into two standalone reportable segments: Thermal & Specialized Solutions (formerly Fluorochemicals) and Advanced Performance Materials (formerly Fluoropolymers). Effective March 1, 2021, Alisha Bellezza will become President, Thermal & Specialized Solutions, and Denise Dignam will become President, Advanced Performance Materials. At that time, Ed Sparks, who currently serves as our President, Fluoroproducts, will assume his newly appointed position as President, Titanium Technologies, as disclosed under Item 5.02 immediately above.


A copy of the press release is furnished hereto as Exhibit 99.2.


Item 9.01Financial Statements and Exhibits.


(d) Exhibits.


99.1Press release (earnings) dated February 11, 2021.


99.2Press release (leadership) dated February 11, 2021.  


104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.







/s/ Sameer Ralhan



Sameer Ralhan



Senior Vice President, Chief Financial Officer




February 11, 2021




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
3/1/21None on these Dates
Filed on / For Period end:2/11/21
 List all Filings 
Filing Submission 0001564590-21-005566   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 12, 4:22:24.0pm ET